Scientists reveal how miRNAs shape cancer and offer new paths for treatment
Groundbreaking research uncovers the role of miRNAs in driving cancer while offering innovative diagnostic tools and therapies, including solutions to ...
Tag: Cell Cycle
Mettl3 guides CD8 T cells to eliminate infected cells with maximum efficiency
This study is led by Dr. Shuyang Yu (College of Biological Sciences, China Agricultural University), Dr. Jingyu Xu (The Collaborative ...
GFH009 disrupts growth signals and triggers apoptosis in hematologic malignancies
A new research paper was published in Oncotarget's Volume 14 on December 20, 2023, entitled, "The pharmacodynamic and mechanistic foundation ...
Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening
The pathogenesis of Alzheimer’s Disease (AD), a leading cause of dementia, remains unclear. One notable limitation of current cellular models ...
Researchers discover new way to target bacterial cell wall
The bacterial cell wall must be constantly remodeled in order to grow and divide. This involves the close coordination of ...
Breast cancer and MEN1: exploring the connection
In a recent publication in the PLOS One Journal, researchers evaluated the role of Multiple Endocrine Neoplasia 1 (MEN1) messenger ...
Combination of two drugs may be more effective in treating resistant breast cancer
Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research. When these cells are confronted ...
New study aims to elucidate the role of p21 in chronic lung inflammation
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" ...
Researchers show how liver cancer cells hijack circadian clock machinery to divide and spread
The most common type of liver cancer, hepatocellular carcinoma (HCC), is already the third leading cause of cancer-related deaths globally-;and ...
Addition of capivasertib to fulvestrant doubles progression-free survival in HR-positive breast cancer patients
In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational AKT inhibitor capivasertib to ...
